Human selenium binding protein-1 (hSP56) is a negative regulator of HIF-1α and suppresses the malignant characteristics of prostate cancer cells |
Jeong, Jee-Yeong
(Laboratory for Cell and Molecular Biology, Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School)
Zhou, Jin-Rong (Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School) Gao, Chong (Laboratory for Cell and Molecular Biology, Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School) Feldman, Laurie (Laboratory for Cell and Molecular Biology, Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School) Sytkowski, Arthur J. (Laboratory for Cell and Molecular Biology, Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School) |
1 | Yang, M. and Sytkowski, A. J. (1998) Differential expression and androgen regulation of the human selenium- binding protein gene hSP56 in prostate cancer cells. Cancer Res. 58, 3150-3153. |
2 | Chang, P. W., Tsui, S. K., Liew, C., Lee, C. C., Waye, M. M. and Fung, K. P. (1997) Isolation, characterization, and chromosomal mapping of a novel cDNA clone encoding human selenium binding protein. J. Cell Biochem. 64, 217-224. DOI |
3 | Wu, C. L., Zhang, W. B., Mai, K. S., Liang, X. F., Xu, W., Wang, J. and Ma, H. M. (2010) Molecular cloning, characterization and mRNA expression of selenium-binding protein in abalone (Haliotis discus hannai Ino): Response to dietary selenium, iron and zinc. Fish Shellfish Immunol. 29, 117-125. DOI ScienceOn |
4 | Zhang, P., Zhang, C., Wang, X., Liu, F., Sung, C. J., Quddus, M. R. and Lawrence, W. D. (2011) The expression of selenium-binding protein 1 is decreased in uterine leiomyoma. Diagn. Pathol. 5, 80. |
5 | Brown, L. M., Helmke, S. M., Hunsucker, S. W., Netea-Maier, R. T., Chiang, S. A., Heinz, D. E., Shroyer, K. R., Duncan, M. W. and Haugen, B. R. (2006) Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue. Mol. Carcinog. 45, 613-626. DOI ScienceOn |
6 | Kim, H., Kang, H. J., You, K. T., Kim, S. H., Lee, K. Y., Kim, T. I., Kim, C., Song, S. Y., Kim, H. J. and Lee, C. (2006) Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics 6, 3466-3476. DOI ScienceOn |
7 | Li, T., Yang, W., Li, M., Byun, D. S., Tong, C., Nasser, S., Zhuang, M., Arango, D., Mariadason, J. M. and Augenlicht, L. H. (2008) Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. Mol. Nutr. Food Res. 52, 1289-1299. DOI ScienceOn |
8 | Zhang, J., Zhan, N. and Dong, W. G. (2010) Altered expression of selenium-binding protein 1 in gastric carcinoma and precursor lesions. Med. Oncol. 28, 951-957. |
9 | Zhang, J., Dong, W. G. and Lin, J. (2011) Reduced selenium- binding protein 1 is associated with poor survival rate in gastric carcinoma. Med. Oncol. 28, 481-487. DOI ScienceOn |
10 | Xia, Y. J., Ma, Y. Y., He, X. J., Wang, H. J., Ye, Z. Y. and Tao, H. Q. (2011) Suppression of selenium-binding protein 1 in gastric cancer is associated with poor survival. Hum. Pathol. 42, 1620-1628. DOI ScienceOn |
11 | Zhang, C., Wang, Y. E., Zhang, P., Liu, F., Sung, C. J., Steinhoff, M. M., Quddus, M. R. and Lawrence, W. D. (2010) Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma. Hum. Pathol. 41, 255-261. DOI ScienceOn |
12 | Jeong, J. Y., Wang, Y. and Sytkowski, A. J. (2009) Human selenium binding protein-1 (hSP56) interacts with VDU1 in a selenium-dependent manner. Biochem. Biophys. Res. Commun. 379, 583-588. DOI ScienceOn |
13 | Li, Z., Wang, D., Messing, E. M. and Wu, G. (2005) VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1alpha. EMBO Rep. 6, 373-378. DOI ScienceOn |
14 | Kaelin, W. G., Jr. and Ratcliffe, P. J. (2008) Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30, 393-402. DOI ScienceOn |
15 | Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S. and Kaelin, W. G., Jr. (2001) HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292, 464-468. DOI ScienceOn |
16 | Semenza, G. L. (2003) Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732. DOI ScienceOn |
17 | Hagg, M. and Wennstrom, S. (2005) Activation of hypoxia-induced transcription in normoxia. Exp. Cell Res. 306, 180-191. DOI ScienceOn |
18 | Flemetakis, E., Agalou, A., Kavroulakis, N., Dimou, M., Martsikovskaya, A., Slater, A., Spaink, H. P., Roussis, A. and Katinakis, P. (2002) Lotus japonicus gene Ljsbp is highly conserved among plants and animals and encodes a homologue to the mammalian selenium-binding proteins. Mol. Plant. Microbe. Interact. 15, 313-322. DOI ScienceOn |
19 | Jamba, L., Nehru, B., Medina, D., Bansal, M. P. and Sinha, R. (1996) Isolation and identification of selenium-labeled proteins in the mouse kidney. Anticancer Res. 16, 1651-1657. |
20 | Sinha, R., Bansal, M. P., Ganther, H. and Medina, D. (1993) Significance of selenium-labeled proteins for selenium's chemopreventive functions. Carcinogenesis 14, 1895-1900. DOI ScienceOn |
21 | Scortegagna, M., Martin, R. J., Kladney, R. D., Neumann, R. G. and Arbeit, J. M. (2009) Hypoxia-inducible factor-1alpha suppresses squamous carcinogenic progression and epithelial-mesenchymal transition. Cancer Res. 69, 2638-2646. DOI ScienceOn |
22 | Pohl, N. M., Tong, C., Fang, W., Bi, X., Li, T. and Yang, W. (2009) Transcriptional regulation and biological functions of selenium-binding protein 1 in colorectal cancer in vitro and in nude mouse xenografts. PLoS One 4, e7774. DOI ScienceOn |
23 | Goldberg, M. A. and Schneider, T. J. (1994) Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 269, 4355-4359. |
24 | Glatt, S. J., Everall, I. P., Kremen, W. S., Corbeil, J., Sasik, R., Khanlou, N., Han, M., Liew, C. C. and Tsuang, M. T. (2005) Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 102, 15533-15538. DOI ScienceOn |
25 | Silvers, A. L., Lin, L., Bass, A. J., Chen, G., Wang, Z., Thomas, D. G., Lin, J., Giordano, T. J., Orringer, M. B., Beer, D. G. and Chang, A. C. (2010) Decreased selenium- binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity. Clin. Cancer Res. 16, 2009-2021. DOI |
26 | Kanazawa, T., Chana, G., Glatt, S. J., Mizuno, H., Masliah, E., Yoneda, H., Tsuang, M. T. and Everall, I. P. (2008) The utility of SELENBP1 gene expression as a biomarker for major psychotic disorders: replication in schizophrenia and extension to bipolar disorder with psychosis. Am J. Med. Genet. B. Neuropsychiatr. Genet. 147B, 686-689. DOI ScienceOn |
27 | Huang, C., Ding, G., Gu, C., Zhou, J., Kuang, M., Ji, Y., He, Y., Kondo, T. and Fan, J. (2012) Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1alpha to promote hepatocellular carcinoma invasiveness. Clin. Cancer Res. 18, 3042-3053. DOI ScienceOn |
28 | Freedman, V. H. and Shin, S. I. (1974) Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3, 355-359. DOI ScienceOn |
29 | Pass, H. I., Liu, Z., Wali, A., Bueno, R., Land, S., Lott, D., Siddiq, F., Lonardo, F., Carbone, M. and Draghici, S. (2004) Gene Expression Profiles Predict Survival and Progression of Pleural Mesothelioma. Clin. Cancer Res. 10, 849-859. DOI ScienceOn |
30 | Chen, G., Wang, H., Miller, C. T., Thomas, D. G., Gharib, T. G., Misek, D. E., Giordano, T. J., Orringer, M. B., Hanash, S. M. and Beer, D. G. (2004) Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas. J. Pathol. 202, 321-329. DOI ScienceOn |
31 | Jeong, J. Y., Feldman, L., Solar, P., Szenajch, J. and Sytkowski, A. J. (2008) Characterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cells. Int. J. Cancer 122, 274-280. DOI ScienceOn |
![]() |